Administrative restriction on a pharmaceutical product
The Supreme Court's Appeals Selection Committee decided on 18 February 2025 that the appeal against Borgarting Court of Appeal's judgment 21 October 2024 will be heard by the Supreme Court.
Merck Sharp & Dohme LLC
(Counsel Knut Sverre Skurdal Andresen)
v.
The State represented by The Norwegian Board of Appeal for Industrial Property Rights
(The Office of the Attorney General represented by Anders Narvestad)
Administrative limitation on a pharmaceutical product. Whether non-independent patent claims can be limited alone. Section 39 a of the Patent Act.